Literature DB >> 22076978

(99m)TC-octreotide scintigraphy and somatostatin receptor subtype expression in juvenile nasopharyngeal angiofibromas.

Wojciech Kukwa1, Renata Andrysiak, Andrzej Kukwa, Alicja Hubalewska-Dydejczyk, Zuzanna Gronkiewicz, Piotr Wojtowicz, Leszek Krolicki, Wojciech Wierzchowski, Tomasz Grochowski, Anna M Czarnecka.   

Abstract

BACKGROUND: The main goal of the study was the analysis of somatostatin receptor (SSTR) expression on juvenile nasopharyngeal angiofibroma (JNA) cells and a subsequent analysis of the utility of SST analog-based scintigraphy in JNA diagnostics.
METHODS: Nine JNA cases were analyzed. All tissue samples were analyzed for the expression of SSTRs. In 2 cases, scintigraphy was performed after the intravenous (IV) administration of an SST analog. MRI of the craniofacial region was subsequently performed.
RESULTS: The SST analogues were accumulated in areas matching pathologic tissue in the nasopharynx. Immunohistochemical evaluation of the tissue samples proved the overexpression of SSTRs.
CONCLUSIONS: SSTRs are overexpressed on JNA cells. The SST analog (99m)TC-octreotide is effectively bound to JNA cells. SST analogues might be used in the diagnostics and treatment of primary, recurrent, or residual JNA.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22076978     DOI: 10.1002/hed.21668

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  2 in total

1.  Clinical Utility of 68Ga-DOTANOC Positron Emission Tomography-Computed Tomography Scan on Postoperative Assessment of Juvenile Nasal Angiofibroma.

Authors:  Pirabu Sakthivel; Alok Thakar; Arun Prashanth; Sreedharan Thankarajan Arunraj; Rakesh Kumar; Rakesh Kumar
Journal:  Indian J Nucl Med       Date:  2020-10-21

2.  Juvenile Nasal Angiofibroma on 68Ga-DOTANOC PET/CT: Exploring Theranostic Avenues.

Authors:  Pirabu Sakthivel; Alok Thakar; Arun Prashanth; Rakesh Kumar; Suresh Chandra Sharma; Rakesh Kumar
Journal:  Indian J Nucl Med       Date:  2020-03-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.